Hopewell Health Centers, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 38900 Ohio State Route 7, Suite 105-a, Reedsville, OH 45772 Phone: 740-570-2002 Fax: 740-570-2010 |
Hopewell Health Centers, Inc. Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 38900 Ohio State Route 7, Suite 105-a, Reedsville, OH 45772 Phone: 740-570-2002 Fax: 740-570-2010 |
News Archive
IGI Laboratories, Inc., a New Jersey based formulation and manufacturing company, today announced that it has submitted its first abbreviated new drug application (ANDA) to the US FDA. IGI President and CEO Charlie Moore commented "This is a significant step forward in validating IGI's commitment to pharmaceutical product development.
TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
AARP Bulletin: This article tells the story of the Bayliss family. Four sisters found themselves "at an impasse" regarding how to care for their 83-year-old mother who was diagnosed with Alzheimer's and experiencing other physical challenges.
About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome.
› Verified 5 days ago